Martin Richard Howard

Title: Martin Richard Howard - Innovator in Cancer Treatment

Introduction

Martin Richard Howard is a prominent inventor based in Cambridge, GB, known for his significant contribution to cancer treatment through his innovative patent. With a passion for advancing medical science, he developed a unique approach to targeting DNA-PK mediated diseases, including cancer, through the creation of purinone compounds.

Latest Patents

Howard holds a notable patent for "Purinone compounds and their use in treating cancer." The patent specification generally relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. These compounds are designed to treat or prevent diseases mediated by DNA-PK, including various forms of cancer. The patent further encompasses pharmaceutical compositions, kits, methods of manufacture, and treatment methods involving these compounds and salts.

Career Highlights

Throughout his career, Martin Richard Howard has been associated with reputable organizations such as AstraZeneca and Cancer Research Technology Limited. His affiliations with these companies have significantly influenced his career, allowing him to work at the forefront of pharmaceutical innovation and research.

Collaborations

In his professional journey, Howard collaborated with notable colleagues like Maurice Raymond Verschoyle Finlay and Frederick Woolf Goldberg. These partnerships have fostered an environment of shared expertise and innovative thinking, further propelling advancements in cancer treatment.

Conclusion

Martin Richard Howard's contributions to the field of cancer treatment through his innovative patent for purinone compounds underscore the importance of collaboration and research in medical advancements. His work continues to inspire future inventions and innovations within the pharmaceutical industry, demonstrating the profound impact one inventor can have on the fight against cancer.